Nymox Pharmaceutical Corp. (NYMX) Stock Quote

Detailed Quote for Nymox Pharmaceutical Corp. (NYMX) 
$ 3.70   -0.08 (-2.12%) Volume: 26.6 k 10:59 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
3.70
Change $
0.08
Change %
2.12%
Tick
  
Bid
3.67
Bid Size
100
Ask
3.71
Ask Size
400
Open
3.77
High
3.881
Low
3.68
Prev Close
3.78
Last Trade
10:59
Volume
26.6 k
52 Wk Hi
5.40
52 Wk Low
2.6401
Market Cap
118.57 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
32,044,744
EPS (TTM)
-0.18
PE Ratio
N/A
Exchange
NSC
News and Media for Nymox Pharmaceutical Corp.  (NYMX) 
Sector News | Topic News
News for NYMX
Fri, Aug 13, 2010
9:49 AM Nymox Reports Second Quarter 2010 Financial Results - Globe Newswire
Wed, Jul 28, 2010
10:01 AM Nymox Reports Safety Monitoring Committee Findings for Pivotal Phase 3 NX-1207 Trials - Globe Newswire
Wed, Jul 21, 2010
11:13 AM Singular Research Initiates Coverage of Nymox With "Buy" Rating - Globe Newswire
Wed, Jul 07, 2010
11:42 AM Nymox Reports Positive New Clinical Trial Data on Improvement in Key Symptom in Patients on NX-1207 Drug for Prostate Enlargement - Globe Newswire
Tue, Jun 22, 2010
11:13 AM Nymox Announces New U.S. Follow-Up Results From Study NX02-0014, BPH Drug NX-1207 Continues to Show Positive Data at 5 Years - Globe Newswire
Tue, Jun 15, 2010
9:52 AM Nymox Reports Near Completion of New Five Year Long-Term Follow-Up NX02-0014 U.S. Study of BPH Drug - Globe Newswire
Mon, Jun 07, 2010
10:59 AM Nymox to Present at Jefferies 2010 Global Life Sciences Conference - Globe Newswire
Wed, Jun 02, 2010
9:46 AM New Positive Data on NX-1207 Presented at Symposium at American Urological Association Annual Meeting - Globe Newswire
Thu, May 27, 2010
12:19 PM Nymox NX-1207 Symposium at American Urological Association Annual Meeting in San Francisco Tuesday June 1 at 3:00 p.m. PDT - Globe Newswire
Tue, May 25, 2010
9:46 AM Nymox Announces 3 Year Follow-Up Results From NX02-0016 U.S. Study of NX-1207 for BPH - Globe Newswire
Thu, May 20, 2010
9:51 AM Symposium on Nymox's NX-1207 BPH Drug to be Held at Annual Meeting of American Urological Association in San Francisco - Globe Newswire
Tue, May 18, 2010
10:01 AM Nymox Nears Completion of New Three Year U.S. Long-Term Follow-Up Study of BPH Drug - Globe Newswire
Fri, May 14, 2010
9:39 AM Nymox Reports First Quarter 2010 Financial Results - Globe Newswire
Tue, May 11, 2010
10:11 AM Nymox Reports Positive Safety Monitoring Committee Update for Pivotal Phase 3 NX-1207 Trials - Globe Newswire
Tue, May 04, 2010
10:11 AM Nymox Announces Positive New Results in 6 Year Study of NX-1207 for Benign Prostatic Hyperplasia - Globe Newswire
Tue, Mar 30, 2010
10:03 AM Nymox's Phase 3 First in Class NX-1207 Drug in Development for Multiple Indications - Globe Newswire
Thu, Mar 11, 2010
9:46 AM Nymox Reports 2009 Financial Results - Globe Newswire
Tue, Feb 09, 2010
11:45 AM Nymox Provides Update on Pivotal Phase 3 Trials for BPH Drug - Globe Newswire
Thu, Jan 07, 2010
10:30 AM New Peer-Reviewed Paper in Expert Opinion on Investigational Drugs Features Nymox NX-1207 Drug for BPH -- Article Suggests Nymox Drug Has Potential to Significantly Impact Current Pattern of Treatment for BPH - Globe Newswire
Thu, Dec 10, 2009
1:00 PM Nymox Announces New $15 Million Equity Financing Commitment - Globe Newswire
More News for NYMX >>

Tags for Nymox Pharmaceutical Corp.

Research stocks or mutual funds related to Nymox Pharmaceutical Corp. by keywords or tags. Find companies that have a similar focus to NYMX. The keywords below have been associated to NYMX by either user submission or electronic means.

alzheimer's dementia difference between dementia and alzheimers familial alzheimer's alzheimer drug alzheimer treatment early onset alzheimers alzheimer support alzheimer dementia alzheimer statistics causes of alzheimer's early signs of alzheimer's alzheimer's disease research center alzheimers stages of alzheimers statistics on alzheimer's disease alzheimer's support groups alzheimers diagnosis dementia prevention history of alzheimer's disease alzheimer's disease treatment end stage alzheimers stages dementia dementia vs alzheimers alzheimer signs alzheimer's disease prognosis alzheimer prevention alzheimer's drugs diagnosing alzheimer's dementia and alzheimers history of alzheimers alzheimer's disease statistics alzheimer's information alzheimers treatment alzheimer's treatments early onset dementia stages of alzheimer's disease Drugs alzheimer's gifts alzheimer's diseases alzheimers activities alzheimers hereditary alzheimers symptoms alzheimers support alzheimer's association early alzheimer's symptoms familial alzheimer's disease prevent alzheimer's alzheimer's disease facts signs of alzheimer's disease causes of alzheimers

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.